IRIS UniCatt

Cefalo, Chiara Maria Assunta
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 1.470
AS - Asia 1.237
EU - Europa 1.011
SA - Sud America 225
AF - Africa 27
OC - Oceania 5
Continente sconosciuto - Info sul continente non disponibili 3
Totale 3.978
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.441
SG - Singapore 574
CN - Cina 277
IT - Italia 210
BR - Brasile 196
DE - Germania 168
SE - Svezia 146
FR - Francia 116
VN - Vietnam 116
GB - Regno Unito 62
PL - Polonia 62
IE - Irlanda 58
FI - Finlandia 55
IN - India 45
ID - Indonesia 33
TR - Turchia 29
UA - Ucraina 28
JP - Giappone 25
HK - Hong Kong 20
KR - Corea 20
RU - Federazione Russa 20
AR - Argentina 16
BE - Belgio 16
CA - Canada 16
SA - Arabia Saudita 16
BD - Bangladesh 15
AT - Austria 12
IQ - Iraq 12
IR - Iran 12
NL - Olanda 12
ES - Italia 10
CH - Svizzera 9
MX - Messico 9
PK - Pakistan 8
UZ - Uzbekistan 7
ZA - Sudafrica 7
AE - Emirati Arabi Uniti 4
AU - Australia 4
AZ - Azerbaigian 4
GR - Grecia 4
KE - Kenya 4
BG - Bulgaria 3
CO - Colombia 3
DZ - Algeria 3
JM - Giamaica 3
LT - Lituania 3
MA - Marocco 3
OM - Oman 3
PH - Filippine 3
PY - Paraguay 3
CI - Costa d'Avorio 2
CL - Cile 2
DK - Danimarca 2
GE - Georgia 2
HR - Croazia 2
JO - Giordania 2
MD - Moldavia 2
PT - Portogallo 2
RE - Reunion 2
RO - Romania 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AL - Albania 1
AM - Armenia 1
BA - Bosnia-Erzegovina 1
BH - Bahrain 1
BO - Bolivia 1
CG - Congo 1
CY - Cipro 1
CZ - Repubblica Ceca 1
EC - Ecuador 1
EG - Egitto 1
ET - Etiopia 1
EU - Europa 1
HU - Ungheria 1
IL - Israele 1
KG - Kirghizistan 1
KZ - Kazakistan 1
LV - Lettonia 1
MY - Malesia 1
NG - Nigeria 1
NZ - Nuova Zelanda 1
PA - Panama 1
PE - Perù 1
SI - Slovenia 1
SN - Senegal 1
SY - Repubblica araba siriana 1
TH - Thailandia 1
TW - Taiwan 1
UY - Uruguay 1
VA - Santa Sede (Città del Vaticano) 1
VE - Venezuela 1
XK - ???statistics.table.value.countryCode.XK??? 1
YT - Mayotte 1
Totale 3.978
Salva come PNG Salva come JPEG
Città #
Singapore 306
Chandler 178
Ashburn 161
San Jose 130
Rome 71
Dublin 58
Warsaw 57
Chicago 56
Beijing 53
Hefei 51
Ho Chi Minh City 49
Los Angeles 49
New York 43
Fairfield 41
Helsinki 38
Wilmington 38
Lauterbourg 34
Jakarta 33
San Mateo 32
Hanoi 30
The Dalles 26
Tokyo 25
Seattle 23
Milan 22
São Paulo 22
Ann Arbor 21
Frankfurt am Main 21
Munich 20
Seoul 19
Dallas 18
Houston 17
Bremen 16
Brussels 16
Hong Kong 16
Kent 15
Marseille 15
Santa Clara 14
Boston 13
Nuremberg 13
Basking Ridge 12
Busto Arsizio 12
Cattolica 12
Council Bluffs 12
Falls Church 12
Nanjing 12
Princeton 12
Moscow 11
Pune 11
Atlanta 10
Izmir 10
Toronto 10
Augusta 9
Cambridge 9
Dearborn 9
Denver 9
London 9
Riyadh 9
Vienna 9
Woodbridge 9
Hangzhou 8
Jacksonville 8
Norwalk 8
Orem 8
Tianjin 8
Turku 8
Zurich 8
Bologna 7
Düsseldorf 7
Paris 7
Amsterdam 6
Brooklyn 6
Dong Ket 6
Haiphong 6
Istanbul 6
Phoenix 6
Tashkent 6
Andover 5
Baghdad 5
Belo Horizonte 5
Brasília 5
Charlotte 5
Chennai 5
Guarulhos 5
Jeddah 5
Lappeenranta 5
Manaus 5
Nürnberg 5
Redwood City 5
Rio de Janeiro 5
Shanghai 5
Stockholm 5
Tabriz 5
Barcelona 4
Cape Town 4
Kish 4
Lahore 4
Lancaster 4
Lawrence 4
Mountain View 4
Nairobi 4
Totale 2.299
Salva come PNG Salva come JPEG
Nome #
Sotagliflozin, the first dual SGLT inhibitor: Current outlook and perspectives 11 Medical and Health Sciences 1103 Clinical Sciences 275
β-Cell Fate in Human Insulin Resistance and Type 2 Diabetes: A Perspective on Islet Plasticity 192
β-Cell Glucose Sensitivity Is Linked to Insulin/Glucagon Bihormonal Cells in Nondiabetic Humans. 189
Pancreaticoduodenectomy model demonstrates a fundamental role of dysfunctional β cells in predicting diabetes 187
Endocrine and Metabolic Insights from Pancreatic Surgery 185
Metabolic consequences of the occlusion of the main pancreatic duct with acrylic glue after pancreaticoduodenectomy 183
Hypovitaminosis D Is Associated with Liver Insulin Resistance in Obese Subjects 170
Increased B-cell workload modulates proinsulin-to-insulin ratio in humans 167
Spotlight on ertugliflozin and its potential in the treatment of type 2 diabetes: Evidence to date 158
Genetic susceptibility of increased intestinal permeability is associated with progressive liver disease and diabetes in patients with non-alcoholic fatty liver disease 152
First-phase insulin secretion: can its evaluation direct therapeutic approaches? 148
Mediterranean diet and the prevention of non-alcoholic fatty liver disease: Results from a case-control study 148
Prediabetes: how pathophysiology drives potential intervention on a subclinical disease with feared clinical consequences 140
Noradrenergic fibers are associated with beta-cell dedifferentiation and impaired beta-cell function in humans 137
Alpha-Lipoic Acid and Glucose Metabolism: A Comprehensive Update on Biochemical and Therapeutic Features 130
β α-Cell glucose sensitivity is linked to insulin/glucagon bihormonal cells in nondiabetic humans 125
Erythrocyte membrane fluidity: A novel biomarker of residual cardiovascular risk in type 2 diabetes 124
The Interplay between Immune System and Microbiota in Diabetes 117
A systematic comparison of protocols for recovery of high-quality rna from human islets extracted by laser capture microdissection 117
Intra-islet insulin synthesis defects are associated with endoplasmic reticulum stress and loss of beta cell identity in human diabetes 111
PREVALENCE OF LIVER STEATOSIS AND METABOLIC SYNDROME IN PATIENTS WITH PSORIASIS 91
Effects of PCSK9 inhibition on glucose metabolism and β-cell function in humans: a pilot study 89
ELF TEST IS A RELIABLE NON INVASIVE TEST FOR FIBROSIS IN NAFLD SUBJECTS 82
Genetic and environmental factors responsible for oxidative stress in now alcoholic fatty liver disease (NAFLD) 79
PREVALENCE OF NONALCOHOLIC FATTY LIVER DISEASE (NAFLD) AND METABOLIC SYNDROME IN PATIENTS WITH PSORIASIS 78
A PROPOSAL MODEL FOR THE NON-INVASIVE ASSESSMENT OF HISTOLOGICAL INFLAMMATION IN PATIENTS WITH NON-ALCOHOLIC FATTY LIVER DISEASE (NAFLD) 76
SERUM SODIUM IS A PREDICTOR OF SURVIVAL FOR "INTERMEDIATE HCC" TREATED WITH TRANSARTERIAL CHEMIOEMBOLIZATION (TACE) 75
Steatohepatitis and type 2 diabetes mellitus are influenced by genetic susceptibility to increased intestinal permeability in patients with non-alcoholic fatty liver disease 73
Pilot Study on the Role of Multidisciplinary Approach in Risk Reduction of Risk of Non- alcoholic Fatty Liver in Subjects with Eating Disorders 59
THE 15 AND 30 MINUTES SAMPLING OF 13C-BREATH TESTING ARE ABLE TO PREDICT SEVERE HEPATIC FIBROSIS AND SEVERITY OF LIVER DISEASE 58
HEPARANASE IN NASH: IS IT AN USEFUL MARKER OF FIBROGENESIS? 54
Liver functional reserve and survival after sunitinib therapy in cirrhotic patients with advanced hepatocellular carcinoma 53
A case-control study on the effect of metabolic gene polymorphisms, nutrition, and their interaction on the risk of non-alcoholic fatty liver disease 36
Totale 4.058
Salva come PNG Salva come JPEG
Categoria #
all - tutte 18.221
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 18.221
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202168 0 0 0 0 0 0 0 0 0 11 43 14
2021/2022334 39 9 22 24 19 13 31 57 13 21 38 48
2022/2023586 56 48 51 90 28 77 27 41 54 41 40 33
2023/2024369 19 84 15 29 25 44 35 21 10 32 19 36
2024/2025780 15 22 67 26 43 27 27 48 95 86 175 149
2025/20261.509 243 57 107 178 242 94 289 77 150 72 0 0
Totale 4.058